Month: August 2016

The Lack of EpiPen Competitors is the FDA’s Fault

There’s a new bout of outrage over an expensive medicine or medical treatment. While the good in question changes each time, the blame always seems to fall on greedy corporations who just aren’t regulated enough. Free markets and capitalism are the scapegoat, even when nothing remotely resembling unhampered markets in health care is in place in the United States.

Read More

Please Support Those Who Help Keep This Site Free

CHANGE LANGUAGE/CAMBIAR IDIOMA

Please Support Those Who Help Keep This Site Free

Please Support Those Who Help Keep This Site Free

Translate »